Correction to: A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome

Notice brève
dc.contributor.authorLegault, Kimberly
dc.contributor.authorBlostein, Mark
dc.contributor.authorCarrier, Marc
dc.contributor.authorKahn, Susan
dc.contributor.authorSchulman, Sam
dc.contributor.authorShivakumar, Sudeep
dc.contributor.authorWu, Cynthia
dc.contributor.authorCrowther, Mark A
dc.date.accessioned2020-05-24T03:46:19Z
dc.date.available2020-05-24T03:46:19Z
dc.date.issued2020-05-18
dc.date.updated2020-05-24T03:46:19Z
dc.description.abstractAn amendment to this paper has been published and can be accessed via the original article.
dc.identifier.citationPilot and Feasibility Studies. 2020 May 18;6(1):67
dc.identifier.urihttps://doi.org/10.1186/s40814-020-00614-0
dc.identifier.urihttps://doi.org/10.20381/ruor-24772
dc.identifier.urihttp://hdl.handle.net/10393/40541
dc.language.rfc3066en
dc.rights.holderThe Author(s)
dc.titleCorrection to: A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome

Fichiers

Trousse originale

Voici les éléments 1 - 1 sur 1
Vignette d'image
Nom:
40814_2020_Article_614.pdf
Taille:
187.86 KB
Format:
Adobe Portable Document Format
Télécharger

Trousse de licence

Voici les éléments 1 - 1 sur 1
Vignette d'image
Nom:
license.txt
Taille:
0 B
Format:
Item-specific license agreed upon to submission
Description:
Télécharger

Collections

Publications par les auteurs d'uOttawa publiés par BioMed Central // uOttawa authored publications from BioMed Central